Immune tolerance induction in severe haemophilia A: A UKHCDO inhibitor and paediatric working party consensus update-Reference-Cited by-同舟云学术

Immune tolerance induction in severe haemophilia A: A UKHCDO inhibitor and paediatric working party consensus update

Published:2021-08-17 Issue:6 Volume:27 Page:932-937
ISSN:1351-8216
Container-title:Haemophilia
language:en
Short-container-title:Haemophilia

Author:

Hart Daniel P.¹^ORCID,Alamelu Jayanthi²,Bhatnagar Neha³,Biss Tina⁴,Collins Peter W.⁵,Hall Georgina³,Hay Charles⁶⁷^ORCID,Liesner Ri⁸^ORCID,Makris Michael⁹^ORCID,Mathias Mary⁸,Motwani Jayashree¹⁰,Palmer Ben⁷,Payne Jeanette¹¹,Percy Charles¹²,Richards Michael¹³,Riddell Anne¹⁴^ORCID,Talks Kate⁴,Tunstall Oliver¹⁵,Chalmers Elizabeth¹⁶^ORCID

Affiliation:

1. Royal London Hospital Haemophilia Centre, Barts and The London School of Medicine and Dentistry, QMUL London UK

2. Evelina London Children's Hospital London UK

3. Oxford Haemophilia Centre Oxford University Trust Oxford UK

4. Newcastle Haemophilia Comprehensive Care Centre The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK

5. Cardiff Haemophilia Centre University of Wales Cardiff Wales UK

6. Manchester Haemophilia Centre Manchester UK

7. National Haemophilia Database United Kingdom Haemophilia centre doctors’ organisation (UKHCDO) Manchester UK

8. Great Ormond Street Hospital for Children NHS Foundation Trust, London UK

9. Sheffield Haemophilia & Thrombosis Centre Royal Hallamshire hospital Sheffield UK

10. Birmingham Children's Hospital NHS Trust, Birmingham UK

11. Sheffield Children's NHS Foundation Trust, Sheffield UK

12. University Hospitals Birmingham NHS Foundation Trust, Birmingham UK

13. Leeds Teaching Hospital NHS Trust, Leeds UK

14. Katharine Dormandy Haemophilia and Thrombosis Centre Royal Free Hospital NHS Foundation Trust, London UK

15. Bristol Royal Hospital for Children University Hospitals Bristol NHS Foundation Trust Bristol UK

16. Royal Hospital for Children Glasgow UK

Publisher

Wiley

Subject

Genetics (clinical),Hematology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/hae.14381

Reference8 articles.

1. Emicizumab Prophylaxis in Hemophilia A with Inhibitors

2. A multicenter, open-label phase 3 study of emicizumab prophylaxis in children with hemophilia A with inhibitors

3. Emicizumab Prophylaxis in Patients Who Have Hemophilia A without Inhibitors

4. First-line immune tolerance induction for children with severe haemophilia A: A protocol from the UK Haemophilia Centre Doctors' Organisation Inhibitor and Paediatric Working Parties

5. The principal results of the International Immune Tolerance Study: a randomized dose comparison

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impacts of the COVID-19 pandemic on pediatric and adult patients with hemophilia;Annals of Hematology;2024-09-14

2. Anti-mCD20 in combination with α-mCXCL13 monoclonal antibody inhibits anti-FVIII antibody development in hemophilia A mice;International Immunopharmacology;2024-09

3. Impacts of the COVID-19 pandemic on pediatric and adult patients with hemophilia;2024-06-20

4. Low‐dose immune tolerance induction for severe hemophilia A inhibitor patients: Immunosuppressants are generally not necessary for inhibitor‐titer below 200 BU/mL;Pediatric Investigation;2024-06

5. Single centre experience of the use of emicizumab in previously untreated and minimally treated patients under 18 months of age;Pediatric Blood & Cancer;2024-03-10